942144-43-6

Basic information

• Product Name: tert-butyl (S)-1-hydroxy-3-((S)-tetrahydro-2H-pyran-3-yl)propan-2-ylcarbamate
• Synonyms: tert-butyl (S)-1-hydroxy-3-((S)-tetrahydro-2H-pyran-3-yl)propan-2-ylcarbamate;CarbaMic acid, N-[(1S)-1-(hydroxyMethyl)-2-[(3R)-tetrahydro-2H-pyran-3-yl]ethyl]-, 1,1-diMethylethyl ester;tert-butyl (S)-1-hydroxy-3-((R)-tetrahydro-2H-pyran-3-yl)propan-2-ylcarbaMate
• CAS NO: 942144-43-6
• Molecular Formula: C₁₃H₂₅NO₄
• Molecular Weight: 259.34
• Mol File: 942144-43-6.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: tert-butyl (S)-1-hydroxy-3-((S)-tetrahydro-2H-pyran-3-yl)propan-2-ylcarbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl (S)-1-hydroxy-3-((S)-tetrahydro-2H-pyran-3-yl)propan-2-ylcarbamate(942144-43-6)
• EPA Substance Registry System: tert-butyl (S)-1-hydroxy-3-((S)-tetrahydro-2H-pyran-3-yl)propan-2-ylcarbamate(942144-43-6)

Safety Data

• Hazardous Substances Data: 942144-43-6(Hazardous Substances Data)

Usage

General Description

Tert-butyl (S)-1-hydroxy-3-((S)-tetrahydro-2H-pyran-3-yl)propan-2-ylcarbamate is a chemical compound that is commonly used in the pharmaceutical industry. It is a carbamate derivative that contains a tert-butyl group and a hydroxypropan-2-yl group. The compound has potential medicinal properties and is often used in the synthesis of pharmaceutical drugs. It may also have applications in research and development of new therapeutic agents. The specific stereochemistry of the compound, with both (S)-configurations, is important for its biological activity and potential pharmacological effects. Overall, tert-butyl (S)-1-hydroxy-3-((S)-tetrahydro-2H-pyran-3-yl)propan-2-ylcarbamate is a valuable chemical with potential uses in the pharmaceutical and biotechnology industries.

Upstream product

• 942144-34-5 (S)-tert-butyl 2,2-dimethyl-4-(((R)-tetrahydro-2H-pyran-3-yl)methyl)oxazolidine-3-carboxylate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 942144-12-9 tert-butyl (2S,4R)-1-hydroxy-4-(hydroxymethyl)hept-6-en-2-ylcarbamate 
• 942144-13-0 (S)-tert-butyl 4-((R)-2-(hydroxymethyl)pent-4-enyl)-2,2-dimethyloxazolidine-3-carboxylate 
• 942144-14-1 (S)-tert-butyl 4-((R)-2-((tert-butyldimethylsilyloxy)methyl)pent-4-enyl)-2,2-dimethyloxazolidine-3-carboxylate 
• 942144-35-6 (S)-tert-butyl 4-((R)-2-((tert-butyldimethylsilyloxy)methyl)-5-hydroxypentyl)-2,2-dimethyloxazolidine-3-carboxylate 
• 942144-36-7 (S)-tert-butyl 4-((R)-2-((tert-butyldimethylsilyloxy)methyl)-5-(methylsulfonyloxy)pentyl)-2,2-dimethyloxazolidine-3-carboxylate 
• 144978-35-8 (S)-ethyl N-tert-butoxycarbonylpyroglutamate 
• 153080-81-0 (2S,4R)-1-tert-butyl 4-allyl-2-ethoxycarbonyl-5-oxopyrrolidine-1-carboxylate 

Downstream Products

• 942145-23-5 (S)-2-(tert-butoxycarbonylamino)-3-((R)-tetrahydro-2H-pyran-3-yl)propyl 4-methylbenzenesulfonate 
• 1093858-57-1 tert-butyl (S)-1-((4-nitrophenoxy)carbonyloxy)-3-((R)-tetrahydro-2H-pyran-3-yl)propan-2-ylcarbamate 
• 942145-39-3 methyl 2-((R)-(3-chlorophenyl)((R)-1-((S)-1-(methylamino)-3-((R)-tetrahydro-2H-pyran-3-yl)propan-2-ylcarbamoyl)piperidin-3-yl)methoxy)ethylcarbamate trifluoroacetate 
• 1013937-63-7 methyl 2-((R)-(3-chlorophenyl)((R)-1-((S)-2-(methylamino)-3-((R)-tetrahydro-2H-pyran-3-yl)propylcarbamoyl)piperidin-3-yl)methoxy)ethylcarbamate trifluoroacetate 
• 942145-24-6 tert-butyl (S)-1-azido-3-((R)-tetrahydro-2H-pyran-3-yl)propan-2-ylcarbamate 
• 942145-26-8 tert-butyl (S)-1-azido-3-((R)-tetrahydro-2H-pyran-3-yl)propan-2-yl(methyl)carbamate 
• 942145-27-9 tert-butyl (S)-1-amino-3-((R)-tetrahydro-2H-pyran-3-yl)propan-2-yl(methyl)carbamate 
• 1093864-75-5 methyl {2-[((R)-(3-chlorophenyl){3-[({(2S)-2-(methylamino)-3-[(3R)-tetrahydro-2H-pyran-3-yl]propyl}amino)carbonyl]phenyl}methyl)oxy]ethyl}carbamate 
• 1093864-97-1 methyl 2-((S)-(3-chloro-5-fluorophenyl)(3-((S)-2-(methylamino)-3-((R)-tetrahydro-2H-pyran-3-yl)propylcarbamoyl)phenyl)methoxy)ethylcarbamate 
• 1093864-96-0 methyl 2-((R)-(3-chloro-5-fluorophenyl)(3-((S)-2-(methylamino)-3-((R)-tetrahydro-2H-pyran-3-yl)propylcarbamoyl)phenyl)methoxy)ethylcarbamate 
• 1093865-51-0 [2-{3-[((S)-2-methoxycarbonylamino-ethoxy)-phenyl-methyl]-benzoylamino}-1-((R)-tetrahydro-pyran-3-ylmethyl)-ethyl]-methyl-carbamic acid tert-butyl ester 
• 1093865-57-6 [2-{3-[((S)-2-methoxycarbonylamino-ethoxy)-m-tolyl-methyl]-benzoylamino}-1-((R)-tetrahydropyran-3-ylmethyl)-ethyl]-methyl-carbamic acid tert-butyl ester 
• 1093865-45-2 methyl {2-[((R)-(3-chlorophenyl){3-[({(2S)-2-[{[(1,1-dimethylethyl)oxy]carbonyl}(methyl)amino]-3-[(3R)-tetrahydro-2H-pyran-3-yl]propyl}amino)carbonyl]phenyl}methyl)oxy]ethyl}carbamate 
• 1093865-63-4 [2-{3-[(3-chloro-5-fluoro-phenyl)-((S)-2-methoxycarbonylamino-ethoxy)-methyl]-benzoylamino}-1-((R)-tetrahydro-pyran-3-ylmethyl)-ethyl]-methyl-carbamic acid tert-butyl ester 

Relevant articles and documents

Discovery of VTP-27999, an alkyl amine renin inhibitor with potential for clinical utility

Structure guided optimization of a series of nonpeptidic alkyl amine renin inhibitors allowed the rational incorporation of additional polar functionality. Replacement of the cyclohexylmethyl group occupying the S1 pocket with a (R)-(tetrahydropyran-3-yl)

RENIN INHIBITORS AND METHOD OF USE THEREOF

Disclosed are aspartic protease inhibitors represented by the following Formula: wherein R1 , R2, R3, R4, R5, R6, R7a, R7b and n are as defined herein, or a pharmaceut